West Virginia · 2026 Regular Session · Bill
HB 5553: Relating to participation in federal prescription drug pricing programs.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 5553 is a bill introduced in the West Virginia House on February 16, 2026. According to its official title, it concerns: Relating to participation in federal prescription drug pricing programs. Primary sponsor: Josh Holstein (Republican). It lists 4 additional sponsors. Most recent recorded action (February 16, 2026): To House Health and Human Resources.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Republican 4
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Josh Holstein | Primary sponsor | Republican | House | 32 |
| Jarred Cannon | Co-sponsor | Republican | House | 21 |
| Joe Funkhouser | Co-sponsor | Republican | House | 98 |
| Linville | Co-sponsor | Not applicable (committee) | — | — |
| Matthew Rohrbach | Co-sponsor | Republican | House | 26 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- To House Health and Human Resources
- Introduced in House
- To Health and Human Resources
- Filed for introduction